Nanobiotix

Nanobiotix
Nanobiotix
Industry Pharmaceutical
Founded 2003
Headquarters Paris, France
Key people Laurent Lévy
( CEO)
Products NanoXrayTM
Employees 31 (2011)>
Website [1]

Nanobiotix is a nanomedicine company dedicated to the development of new treatments for cancer based on the combined application of nanotechnologies and biotechnologies.[1] The company is based in Paris.


Contents

History

Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo that was incorporated in 2003 [2] and has been primarily funded by leading European venture capital firms (Matignon Technologies, OTC Asset Management, Cap Decisif, Amorcage Rhone-Alpes, CIC Vizille; Masseran Gestion-CGE).

Corporate structure

  • Chief Executive Officer (CEO) and Chairman of the Board: Laurent Levy
  • Chief Financial Officer (CFO) and (COO): Kader Boussaha [3]

Therapeutics

Nanobiotix has developed a new class of therapeutics based on nanoparticles, NanoXray™ therapeutics. [4] They consist of inert nanoparticles designed to enter tumor cells. Upon activation by a standard dose of radiation, they release a tremendous amount of energy that destroys cancer cells, whilst the surrounding healthy tissues are preserved and receive the same dose of radiation as in standard radiotherapy.[5]

Research and development

Nanobiotix has already won 10 public and private awards and owns 9 original umbrella patents. [6]

Pipeline:

  • NBTXR3


References

External links


Wikimedia Foundation. 2010.

Игры ⚽ Нужна курсовая?

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”